NCT07016399 2025-10-30
Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC
Vanderbilt-Ingram Cancer Center
Phase 2 Recruiting
Clinical Trials
4 trialsNCT02620280 2024-03-06
NeoTRIPaPDL1
Fondazione Michelangelo
Phase 3 Completed
NCT05843292 2023-06-06
NeoSTEP
Shanghai Jiao Tong University School of Medicine
Phase 4 Not yet recruiting
NCT01009437 2017-12-05
Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer
Masonic Cancer Center, University of Minnesota
Phase 1 Completed